Research Articles
Standardizing Differentiation Efficiency in Patient-Specific Stem Cell Lines: From Foundational Challenges to Clinical Translation
This article addresses the critical challenge of variability in differentiation efficiency across patient-specific stem cell lines, a major bottleneck in regenerative medicine and drug development.
Addressing Genomic Instability in iPSC Cultures: Mechanisms, Monitoring, and Mitigation Strategies for Research and Therapy
The profound therapeutic potential of induced pluripotent stem cells (iPSCs) is tempered by the significant challenge of genomic instability, which can compromise experimental results and pose serious risks in clinical...
Optimizing Cryopreservation and Thawing for Personalized Stem Cell Products: A Guide for Maximizing Viability and Therapeutic Potential
This article provides a comprehensive guide for researchers and drug development professionals on optimizing cryopreservation and thawing processes for personalized stem cell therapies.
Overcoming Immune Rejection in Allogeneic Stem Cell Transplantation: From Genetic Engineering to Clinical Applications
Allogeneic stem cell transplantation holds transformative potential for treating hematologic cancers and genetic disorders, but immune rejection remains a significant barrier to its broad application.
Strategies for Preventing Teratoma Formation in Pluripotent Stem Cell Therapies: A 2025 Review of Safety Assessment and Risk Mitigation
This article provides a comprehensive analysis of current strategies and emerging technologies for mitigating teratoma formation risk in human pluripotent stem cell (hPSC)-derived therapies.
Engineering Regeneration: Integrating Stem Cells and Biomaterial Scaffolds for Advanced Tissue Repair
This article provides a comprehensive overview of the latest strategies in tissue engineering that combine stem cells with advanced biomaterial scaffolds.
Decoding Cellular Heterogeneity: A Guide to Single-Cell RNA Sequencing for Patient-Derived Stem Cell Lines
Single-cell RNA sequencing (scRNA-seq) is revolutionizing the characterization of patient-derived stem cell lines by providing unprecedented resolution of cellular heterogeneity, dynamic transitions, and drug response mechanisms.
GMP Compliance in Patient-Specific Stem Cell Therapies: From Foundational Principles to Commercial Manufacturing
This article provides a comprehensive guide to Good Manufacturing Practice (GMP) compliance for researchers and drug development professionals navigating the complex transition from laboratory research to clinical manufacturing of patient-specific...
Scaling the Future: Bioreactor Systems for Personalized Stem Cell Therapies
The transition of personalized stem cell therapies from laboratory research to clinical application is contingent on overcoming significant manufacturing challenges.
Stem Cell-Derived Exosomes: Engineering a Personalized Future for Regenerative Therapy
This article provides a comprehensive analysis of stem cell-derived exosomes as a next-generation, cell-free platform for personalized regenerative medicine.